Search Videos and More
News
Fox Chase Researcher Parth Desai Receives Prestigious ASCO Career Development Award
A Fox Chase Cancer Center researcher has received a prestigious national award to advance a novel immunotherapy strategy aimed at one of oncology's most persistent challenges: tumors that resist immune-based treatments.
News
First-in-Human Study Tests Gamitrinib Designed to Disrupt Cancer Cells’ Energy Systems
Cancer cells need large amounts of energy to survive and multiply. To produce that energy, they rely on structures inside the cell called mitochondria, often described as the cell’s “powerhouse.” Unlike healthy cells, cancer cells rely heavily on specialized helper proteins to keep mitochondria functioning under the high stress of rapid growth.
News
Fox Chase – Temple Urologic Institute at AUA 2026
Visit the Fox Chase-Temple Urologic Institute Booth #2464 in the Science & Technology Hall.
Symposium
24th Annual Highlights of the 2025 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2025 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.
News
Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors
According to new research from Fox Chase Cancer Center, radiation therapy administered before surgery rarely produces favorable responses in patients with retroperitoneal sarcoma (RPS), a rare and aggressive cancer that forms in the abdomen. The study reinforces findings from a major international clinical trial and suggests that, due to ineffectiveness, radiation should not be used to shrink tumors before surgery.
News
Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies
A study found that outpatient observation cut hospital stays dramatically, with no adverse safety events reported. It also freed up inpatient beds and cut healthcare costs.
News
The Multi-Institutional Hematopathology Interesting Case Conference: A Brain Trust That Impacts Cancer Diagnoses Worldwide
The foundation of every cancer diagnosis starts behind the scenes, where a pathologist and a team of specialists painstakingly evaluate a patient’s molecular, cytogenetic, and flow cytometry testing to determine whether the individual has cancer, and if so, precisely what type of malignancy, its stage, and how extensive the cancer may be.
News
Study Reveals Hidden Immune Defense Mechanism That Could Be Used to Fight Cancer
In a new study published in the prestigious journal Nature, researchers at Fox Chase Cancer Center have uncovered a new mechanism by which the body’s immune system responds to viral infections, a finding that can potentially be harnessed to attack cancer.
News
Fox Chase Cancer Center and Temple Researchers Highlight Need for Molecular Testing in Diagnosing Two Types of Kidney Cancer
Genetic testing may be the most effective way for researchers to distinguish between a rare form of kidney cancer and another that is more common, potentially preventing misdiagnoses, according to a recent study by researchers at Fox Chase Cancer Center and Temple University Hospital.
News
Fox Chase – Temple Urologic Institute’s Jennifer Kelly Becomes First Temple Health Nurse to Earn Certification from Society of Urologic Nurses & Associates
Jennifer Kelly, BSN, RN, CURN, a nurse with the Fox Chase-Temple Urologic Institute, has become the first nurse in the Temple Health system to earn certification from the Society of Urologic Nurses & Associates (SUNA).
News
Newer Radiation Technique Reduces Side Effects While Maintaining Effectiveness
Researchers at Fox Chase Cancer Center have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with esophageal cancer and non-small cell lung cancer.
Video
Beyond the Routine – Adapt or Not?
Challenges and Dilemmas in Adaptive Radiation Treatment Planning